Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2026-01-01 @ 12:47 AM
Study NCT ID:
NCT06786533
Status:
RECRUITING
Last Update Posted:
2025-08-14
First Post:
2025-01-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML
Sponsor:
Hemogenyx Pharmaceuticals LLC